ios press goodbye analytical cellular pathology, hello...

2
Analytical Cellular Pathology 25 (2003) 209 209 IOS Press Goodbye Analytical Cellular Pathology, hello Cellular Oncology! This is the last issue of Analytical Cellular Pathol- ogy, that brings you the abstracts of the last confer- ence of the European Society for Analytical Cellular Pathology (ESACP) that was held at the VU Univer- sity in Amsterdam, The Netherlands, from 1–4 Octo- ber 2003. This meeting (the International Conference on Applied Genomics) was a joint meeting with the In- ternational Society for Analytical Cellular Pathology (ISDQP). This joint meeting was the final one in a se- ries of joint meetings between the two Societies, illus- trating how close the Societies had grown together over the years. Traditionally, the ESACP had more focus on quantitative biology and technology, but in recent years there has been more interest in clinical applica- tions as was apparent on the various meetings of the Society. The ISDQP had traditionally more focus on applications of quantitative techniques, but had shifted more towards newer technology and biology in recent years. The Societies shared many members, but were both relatively small. After extensive talks between the boards of the two Societies, it became clear that the only way to go forward was to merge the two Societies. This process has taken several years, during which a draft of the constitution for the new Society was formed, the members of both mother Societies were in- formed and heard, and ballots were organized to vote on the merger and the constitution draft. During the Amsterdam meeting, this process has come to a close. Had the ISDQP members voted favourably before, the ESACP members accepted the proposals during the Amsterdam meeting. Thereby, the ESACP and ISDQP were closed, and a new society was formed, which will be called the International Society for Cellular Oncol- ogy (ISCO). The interim board of ISCO, which is com- posed of the officers of the mother Societies and which will be in function until proper elections at the next ISCO meeting in Belfast in 2005, believes this name to reflect best what we have done in the past, do now and/or want to do in the years to come: to study cellular processes in cancer. Cancer has been the focus of most activities within both mother Societies anyway, but of course technology will keep us connected with those studying other diseases. ISCO will be able to host all traditional activities of the mother Societies, but will create new opportunities as we will be better visibly to and thereby more attractive for scientists and clinicians working in cancer biology and genomics. Hopefully, this will lead to larger membership of ISCO and bigger meetings. The new Society deserves a new Journal. The ISQDP had Analytical and Quantitative Cytology and Histology as its (unowned) home journal, and the ESACP owned Analytical Cellular Pathology (ACP). The best solution in the end was to re-launch ACP as Cellular Oncology”, with a new board, a new editor, and new looks. All this is being worked on, and we hope to announce the new editor and the new board soon. Cellular Oncology will have a website where all papers will be electronically available, and will in- herit the impact factor from ACP to make sure the new Journal won’t have to survive the usual first few dif- ficult years without this important bibliographic mea- sure. Further, we will have to work on an electronic submission and reviewing system. All this will give Cellular Oncology a good chance of success, but natu- rally it will take the lasting efforts of all of us to invest in our own new Journal with good papers. Paul J. van Diest, MD, PhD President of the International Society for Cellular Oncology 0921-8912/03/$8.00 2003 – IOS Press. All rights reserved

Upload: vannga

Post on 24-Mar-2018

217 views

Category:

Documents


2 download

TRANSCRIPT

Analytical Cellular Pathology 25 (2003) 209 209IOS Press

Goodbye Analytical Cellular Pathology,hello Cellular Oncology!

This is the last issue ofAnalytical Cellular Pathol-ogy, that brings you the abstracts of the last confer-ence of the European Society for Analytical CellularPathology (ESACP) that was held at the VU Univer-sity in Amsterdam, The Netherlands, from 1–4 Octo-ber 2003. This meeting (the International Conferenceon Applied Genomics) was a joint meeting with the In-ternational Society for Analytical Cellular Pathology(ISDQP). This joint meeting was the final one in a se-ries of joint meetings between the two Societies, illus-trating how close the Societies had grown together overthe years. Traditionally, the ESACP had more focuson quantitative biology and technology, but in recentyears there has been more interest in clinical applica-tions as was apparent on the various meetings of theSociety. The ISDQP had traditionally more focus onapplications of quantitative techniques, but had shiftedmore towards newer technology and biology in recentyears. The Societies shared many members, but wereboth relatively small. After extensive talks between theboards of the two Societies, it became clear that theonly way to go forward was to merge the two Societies.

This process has taken several years, during whicha draft of the constitution for the new Society wasformed, the members of both mother Societies were in-formed and heard, and ballots were organized to voteon the merger and the constitution draft. During theAmsterdam meeting, this process has come to a close.Had the ISDQP members voted favourably before, theESACP members accepted the proposals during theAmsterdam meeting. Thereby, the ESACP and ISDQPwere closed, and a new society was formed, which willbe called the International Society for Cellular Oncol-ogy (ISCO). The interim board of ISCO, which is com-posed of the officers of the mother Societies and whichwill be in function until proper elections at the nextISCO meeting in Belfast in 2005, believes this name

to reflect best what we have done in the past, do nowand/or want to do in the years to come: to study cellularprocesses in cancer. Cancer has been the focus of mostactivities within both mother Societies anyway, but ofcourse technology will keep us connected with thosestudying other diseases. ISCO will be able to host alltraditional activities of the mother Societies, but willcreate new opportunities as we will be better visibly toand thereby more attractive for scientists and cliniciansworking in cancer biology and genomics. Hopefully,this will lead to larger membership of ISCO and biggermeetings.

The new Society deserves a new Journal. TheISQDP hadAnalytical and Quantitative Cytology andHistology as its (unowned) home journal, and theESACP ownedAnalytical Cellular Pathology (ACP).The best solution in the end was to re-launch ACP as“Cellular Oncology”, with a new board, a new editor,and new looks. All this is being worked on, and wehope to announce the new editor and the new boardsoon.Cellular Oncology will have a website whereall papers will be electronically available, and will in-herit the impact factor from ACP to make sure the newJournal won’t have to survive the usual first few dif-ficult years without this important bibliographic mea-sure. Further, we will have to work on an electronicsubmission and reviewing system. All this will giveCellular Oncology a good chance of success, but natu-rally it will take the lasting efforts of all of us to investin our own new Journal with good papers.

Paul J. van Diest, MD, PhDPresident of the International Society for

Cellular Oncology

0921-8912/03/$8.00 2003 – IOS Press. All rights reserved

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com